Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials

Purpose. The addition of cetuximab to radiochemotherapy (RCT) failed to improve complete response rates in locally advanced rectal cancer (LARC). We report the long-term results in patients treated within two sequential clinical trials. Methods. Patients receiving neoadjuvant RCT using capecitabine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Gastroenterol Res Pract
Main Authors: Kripp, M., Horisberger, K., Mai, S., Kienle, P., Gaiser, T., Post, S., Wenz, F., Merx, K., Hofheinz, R.-D.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4377474/
https://ncbi.nlm.nih.gov/pubmed/25861256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/273489
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados